AusPAR: Rivaroxaban

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

29 October 2013
AusPAR Details
AusPAR
AusPAR: Rivaroxaban (pdf, 615 KB)
AusPAR: Rivaroxaban (docx, 690 KB)
Attachment: Product Information: Rivaroxaban (pdf, 367 KB)
Attachment: Product Information: Rivaroxaban (docx, 148 KB)
Attachment: Extract from Clinical Evaluation Report: Rivaroxaban (pdf, 828 KB)
Attachment: Extract from Clinical Evaluation Report: Rivaroxaban (docx, 1 MB)
Active Ingredient
Rivaroxaban
Product Name
Xarelto
Sponsor
Bayer Australia Limited
Submission Number
PM-2012-01179-3-3
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
2 October 2013
Publication Date

29 October 2013
Tags: 
AusPARs
URL: 
https://www.tga.gov.au/node/950